(VIANEWS) – Shares of 10x Genomics (NASDAQ Composite: TXG) dropped 8.4% to $169.00 at 05:26 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ Composite is sliding 0.07% to $15,105.58, after four successive sessions in a row of losses. This seems, as yet, a somewhat negative trend exchanging session today.
10x Genomics’s last close was $185.21, 11.38% below its 52-week high of $208.99.
Today’s last reported volume for 10x Genomics is 782453 which is 21.64% above its average volume of 643207.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the present quarter and 33.2% for the next. The company’s growth estimates for the ongoing quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $169.00 at 05:26 EST, way under its 52-week high of $208.99 and way higher than its 52-week low of $115.39.
10x Genomics’s Moving Average
10x Genomics’s value is under its 50-day moving average of $172.88 and below its 200-day moving average of $176.77.
More news about 10x Genomics (TXG).